ZHANG Junzhan. Clinical efficacy and safety of ipratropium bromide combined with budesonide and salbutamol in the treatment of acute exacerbations of chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2019, (3): 57-59. DOI: 10.7619/jcmp.201903015
Citation:
|
ZHANG Junzhan. Clinical efficacy and safety of ipratropium bromide combined with budesonide and salbutamol in the treatment of acute exacerbations of chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2019, (3): 57-59. DOI: 10.7619/jcmp.201903015
|
ZHANG Junzhan. Clinical efficacy and safety of ipratropium bromide combined with budesonide and salbutamol in the treatment of acute exacerbations of chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2019, (3): 57-59. DOI: 10.7619/jcmp.201903015
Citation:
|
ZHANG Junzhan. Clinical efficacy and safety of ipratropium bromide combined with budesonide and salbutamol in the treatment of acute exacerbations of chronic obstructive pulmonary disease[J]. Journal of Clinical Medicine in Practice, 2019, (3): 57-59. DOI: 10.7619/jcmp.201903015
|